NCCU Appoints New Leaders for Biomedical Initiatives
North Carolina Central University has announced the appointment of key figures to lead its biomedical research, biomanufacturing, and industry partnerships. Kevin Williams, Ph.D., has assumed the role of director for both the Biomanufacturing Research Institute and Technology Enterprise (BRITE) and the Julius L. Chambers Biomedical/Biotechnology Research Institute (BBRI). His appointment became effective on October 1, 2026.
Williams, who has over 35 years of experience in academia and the biotechnology sector, currently holds the position of Merck Professor in Integrated Biosciences and is a professor in the department of pharmaceutical sciences at NCCU. His extensive background includes a significant tenure at Biogen, where he worked in protein engineering for 15 years before joining NCCU in 2007. Since then, he has successfully obtained funding for various research projects and workforce training from notable organizations including the National Institutes of Health and the U.S. Department of Defense. His research primarily focuses on therapeutic discovery aimed at treating cancer and developmental disorders while fostering interdisciplinary collaboration across multiple fields.
New Leadership Team in Place
In addition to Williams, Rob Onyenwoke, Ph.D., and Alex Marshall, Ph.D., have been appointed as associate directors of BRITE and BBRI, respectively, also effective October 1. Onyenwoke, who is currently an assistant professor in the department of biological and biomedical sciences at NCCU, leads a $6.2 million initiative from the U.S. Economic Development Administration aimed at enhancing workforce opportunities in North Carolina’s biomanufacturing and biopharmaceutical sectors. His research focuses on lung inflammatory responses and developing new therapeutic interventions.
Marshall serves as an associate professor in the same department and directs the master’s program in biological and biomedical sciences. His research investigates the neurobiological factors associated with alcohol misuse and related disorders, utilizing various methodologies to identify therapeutic targets. His work is supported by multiple federal grants and contributes to the development of the next generation of biomedical scientists.
Focus on Economic Development
The appointments are part of the newly formed Division of Transformative Partnerships and Economic Development, which is overseen by Kuldeep Rawat, Ph.D., who was appointed vice chancellor for this division on July 1, 2026. Rawat brings over 25 years of experience in industry and academia, previously serving as the Thorpe Endowed Professor and dean at Elizabeth City State University. His role involves positioning NCCU as a preferred partner for industry collaborations while advancing the university’s research goals and capitalizing on its location near Research Triangle Park.
Source: North Carolina Central University
